SOX9 and pulmonary fibrosis: In contrast, in inflammatory diseases—including bone and joint disorders, hepatitis, and pulmonary fibrosis—SOX9 activation exerts beneficial effects by enhancing macrophage activity, inhibiting it pyroptosis, and promoting tissue repair, making it a promising therapeutic target.